ArticleCureus2026
Macular Telangiectasia Type 2: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macular telangiectasia (MacTel) type 2, or juxtafoveal telangiectasia, refers to several vascular abnormalities affecting the capillaries of the foveal and perifoveal regions. It is a progressively degenerative disorder that reduces quality of life by impairing both distance and near vision. This report pertains to a series of five cases of MacTel type 2 that presented to our Outpatient Department. The patients, in their 50s, presented with metamorphopsia and reduced reading skills. The diagnosis was determined through bilateral anomalous macular presentations, asymmetric foveal pit configuration, disruptions in the inner segment/outer segment layer, and hyperreflectivity and shadowing noted at the fovea on optical coherence tomography (OCT). This series highlights the spectrum of clinical and OCT manifestations and underscores the importance of early detection to prevent misinterpretation and unnecessary interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.